Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group

OBJECTIVE: According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in patients with intermediate risk (IR) and high-intermediate risk (HIR) endo...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Gynecol Oncol
मुख्य लेखकों: Reboux, Pierre-Alain, Azaïs, Henri, Canova, Charles-Henry, Bendifallah, Sofiane, Ouldamer, Lobna, Raimond, Emilie, Hudry, Delphine, Coutant, Charles, Graesslin, Olivier, Touboul, Cyril, Collinet, Pierre, Bricou, Alexandre, Huchon, Cyrille, Daraï, Emile, Ballester, Marcos, Lévêque, Jean, Lavoué, Vincent, Koskas, Martin, Uzan, Catherine, Canlorbe, Geoffroy
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543117/
https://ncbi.nlm.nih.gov/pubmed/31074238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e53
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन